Edwards Drives Less-Invasive Valves Via IDE Study, Eventual HDE
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will pursue a humanitarian device exemption for its percutaneous heart valve only after trial enrollment is completed